- Home
- KALV vs NRDS Comparison
KALV vs NRDS Comparison
Compare KALV & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- NRDS
- Stock Information
- Founded
- KALV N/A
- NRDS 2009
- Country
- KALV United States
- NRDS United States
- Employees
- KALV N/A
- NRDS N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- NRDS EDP Services
- Sector
- KALV Health Care
- NRDS Technology
- Exchange
- KALV Nasdaq
- NRDS Nasdaq
- Market Cap
- KALV 796.4M
- NRDS 785.4M
- IPO Year
- KALV N/A
- NRDS 2021
- Fundamental
- Price
- KALV $11.08
- NRDS $11.19
- Analyst Decision
- KALV Strong Buy
- NRDS Buy
- Analyst Count
- KALV 8
- NRDS 5
- Target Price
- KALV $26.43
- NRDS $13.80
- AVG Volume (30 Days)
- KALV 1.5M
- NRDS 478.2K
- Earning Date
- KALV 12-04-2025
- NRDS 11-06-2025
- Dividend Yield
- KALV N/A
- NRDS N/A
- EPS Growth
- KALV N/A
- NRDS N/A
- EPS
- KALV N/A
- NRDS 0.60
- Revenue
- KALV $1,426,000.00
- NRDS $771,200,000.00
- Revenue This Year
- KALV N/A
- NRDS $16.45
- Revenue Next Year
- KALV $209.38
- NRDS $7.85
- P/E Ratio
- KALV N/A
- NRDS $18.03
- Revenue Growth
- KALV N/A
- NRDS 28.75
- 52 Week Low
- KALV $7.30
- NRDS $7.55
- 52 Week High
- KALV $17.28
- NRDS $16.45
- Technical
- Relative Strength Index (RSI)
- KALV 38.81
- NRDS 58.68
- Support Level
- KALV $10.75
- NRDS $10.62
- Resistance Level
- KALV $12.23
- NRDS $11.04
- Average True Range (ATR)
- KALV 0.62
- NRDS 0.37
- MACD
- KALV -0.01
- NRDS 0.02
- Stochastic Oscillator
- KALV 22.25
- NRDS 86.85
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.